When redesigning their workplaces, leaders must reflect on employees' best interests, versus their own.

Global Head, Health Services, Oliver Wyman
Partner, Financial Services, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Digital, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Organizational Effectiveness & Transformation, Oliver Wyman

Access Will Become Commoditized

Providers’ strategic control and differentiation will shift to be based on experience, ease of use, and price.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Engagement Manager, Health & Life Sciences, Oliver Wyman

Imagine a future where leveraging our DNA and what we know about it prevents illness and improves care outcomes.

Co-Founder and CEO, Genome Medical, and 2020 Tom Main Health Innovation Mentorship Winner

Our predictions on what inevitable movements, mindsets, and actions will unfold in healthcare over the next decade.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Addressing Racism and Weathering Among Marginalized Communities

Addressing racism is a marathon, not a sprint. Healthcare leaders must be willing to take the first step to initiate heavy conversations that drive progress.

Co-Founder and CMO, Eleanor Health
Principal, Oliver Wyman

Insights in your inbox

Subscribe

Researchers were surprised by the variable that best predicted fatalities.

Charles Moskos Professor of Economics, Northwestern University
MUFG Bank Distinguished Professor of International Finance, Kellogg School of Management
Research Fellow, Freie Universität Berlin

Plus, Why We Should Still Be Thinking About Cumulative Population Immunity

Three takeaways from our analysis on possible Herd Immunity Threshold and how to reach it together.

Partner, Health and Life Sciences, Oliver Wyman
Partner and Vice Chairman, Financial Services, Americas, Oliver Wyman
Partner and CMO, Health and Life Sciences, Oliver Wyman
Managing Partner, Health and Life Sciences, and Global Chair for I&D, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

With the pandemic accelerating transformation, AMC strategies must reimagine their operations to deliver new value.

Director, Marsh & McLennan Advantage, Healthcare
Partner, Health and Life Sciences, Oliver Wyman
Engagement Manager, Health & Life Sciences, Oliver Wyman

Supporting leaders in pursuit of health transformation, Oliver Wyman joined forces with venture capitalist firms on a new mentorship program.

Considerations for Consumers, Providers, and Payers

The concept of “healthcare delivery” is dramatically shifting and opportunities for stakeholders abound.

VP of Client Delivery, Quil

Insights in your inbox

Subscribe
Load More